|4Jun 3, 11:53 AM ET

bluebird bio, Inc. 4

4 · bluebird bio, Inc. · Filed Jun 3, 2015

Insider Transaction Report

Form 4
Period: 2015-06-01
Finer Mitchell H.
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2015-06-01$188.59/sh4,842$913,13110,158 total
  • Sale

    Common Stock

    2015-06-01$191.42/sh4,022$769,8881,437 total
  • Sale

    Common Stock

    2015-06-01$193.31/sh375$72,492249 total
  • Sale

    Common Stock

    2015-06-01$195.06/sh166$32,3810 total
  • Exercise/Conversion

    Common Stock

    2015-06-01$24.47/sh+15,000$367,05015,000 total
  • Sale

    Common Stock

    2015-06-01$189.25/sh1,593$301,4808,565 total
  • Sale

    Common Stock

    2015-06-01$190.57/sh3,106$591,9075,459 total
  • Sale

    Common Stock

    2015-06-01$192.36/sh813$156,389624 total
  • Sale

    Common Stock

    2015-06-01$194.35/sh83$16,131166 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-06-0115,00040,000 total
    Exercise: $24.47Exp: 2024-03-03Common Stock (15,000 underlying)
Footnotes (10)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014.
  • [F10]This option vests over a four-year period, at the rate of twenty-five percent (25%) on January 1, 2015, and in 36 equal monthly installments thereafter.
  • [F2]The range of prices for the transaction reported on this line was $188.22 to $188.99. The average weighted price was $188.5856. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The range of prices for the transaction reported on this line was $189.13 to $189.50. The average weighted price was $189.2530. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]The range of prices for the transaction reported on this line was $190.00 to $190.91. The average weighted price was $190.5689. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]The range of prices for the transaction reported on this line was $191.01 to $191.93. The average weighted price was $191.4193. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]The range of prices for the transaction reported on this line was $192.00 to $192.64. The average weighted price was $192.3605. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F7]The range of prices for the transaction reported on this line was $193.00 to $193.75. The average weighted price was $193.3133. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F8]The range of prices for the transaction reported on this line was $194.35 to $194.35. The average weighted price was $194.3500. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F9]The range of prices for the transaction reported on this line was $195.01 to $195.12. The average weighted price was $195.0650. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION